There is until this point not a convincing biological model for the observation that presumed MHC class I binding peptides (87), delivered as 9mers, induce rather CD4+ T-cell responses as compared to CD8+ T-cells; an observation that has been found to be true in several vaccination studies using tumor-associated mutant targets (69). The gene discussed is CD4; the disease is neoplasm.